Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.03 · Revenue $10.03M · 2 analysts
Est. EPS $-0.02 · Revenue $14.27M · 2 analysts
Est. EPS $-0.11 · Revenue $41.20M · 2 analysts
Est. EPS $0.01 · Revenue $16.55M · 1 analysts
EPS $0.01 · Revenue $8.01M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $33.3M | +71.0% | -8.2% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $1.3M | +90.7% | -58.1% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +62.8% | -20.7% | -5.3% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +4.6% | -9.7% | -73.5% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +3.8% | +11.5% | -72.1% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-56108 | -104.4% | +30.7% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -0.2% | -102.6% | +24.6% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 0.8% | -47.9% | -6.5% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 3.13x | -38.1% | -30.7% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $23.1M | +46.4% | +7.2% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 0.02 vs 0.01 | +33.3% | -0.04 vs -0.03 | -50.0% |
| Revenue Surprise | $33.3M vs $32.4M | +3.0% | $8.1M vs $7.8M | +3.5% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Qian LinLin | director, 10 percent owner, officer: Chief Financial Officer | Class A Common Stock | D | 28,183 | $1.06 |
| Aug 13, 2026 | Johnson Tim Donald | director, 10 percent owner, officer: Chief Executive Officer | Class A Common Stock | D | 46,327 | $1.06 |
| Aug 13, 2026 | Hasan Zain Syed | officer: Chief Growth Officer | Class A Common Stock | D | 4,007 | $1.06 |
| Jul 15, 2026 | Hasan Zain Syed | officer: Chief Growth Officer | Class A Common Stock | D | 4,084 | $1.04 |
| Jul 15, 2026 | Johnson Tim Donald | director, 10 percent owner, officer: Chief Executive Officer | Class A Common Stock | D | 47,217 | $1.04 |
Operator: Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health In Tech Second Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, we are recording today's call. [Operator Instructions] Now I would like to turn the conference over to Ms. Lori Babcock, Chief of Staff for the company. Ms. Babcock, please proceed. Lori Babcock: Thank you, operator, and hello, everyone. Welcome to Health In Tech's Second Quarter 2026 Earnings Conference Call. Joining us today are Mr. Tim Johnson, Chief Executive Officer; and Ms. Julia Qian, Chief Financial Officer. Full details of our results can be found in our earnings press release and in our related Form 10-Q recently filed with the SEC. These documents will be available on our Investor Relations website at healthintech.investorroom.com. As a reminder, today's call is being recorded, and a replay will be available on our IR website as well. Before we continue, please note that today's discussion includes forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based on information available as of today and involve risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied, including those discussed in our quarterly report on Form 10-Q for the period ended June 30, 2026, filed with the SEC. Please review the forward-looking and cautionary statements section at the end of our earnings release for various factors that could cause actual results to differ materially from forward-looking statements made during our call today. Except as expressly required by the federal securities law, we undertake no obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events. We may also refer to certain financial measures not in accordance with generally accepted accounting principles such as adjusted EBITDA for comparison purposes only. Our GAAP results and reconciliations of GAAP to non-GAAP measures can be found in our earnings press release. With that, I now turn the call over to our CEO, Mr. Tim Johnson. Tim Johnson: Thanks, Lori, and good afternoon, everyone. We appreciate you joining us today. Before I get into the quarter, I want to take some time to reiterate because I think it's important for everyone on this call to understand exactly what kind of company we are building. Health In Tech is a young and very dynamic company. We are still early in our journey, but we operate with a business model, a technology foundation and a market opportunity in front of us that we believe will continue to drive enterprise value for the company. That is not about next quarter. It is a statement about the architecture and foundation of this business. …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Tim Johnson | Founder, Chief Executive Officer & Chairman | USD 420,000 | Male | 1965 | Active |
Jonathan Lockett | Chief Strategy Officer | USD 401,000 | Male | 1962 | Active |
Julia Qian | Chief Financial Officer & Director | USD 360,000 | Female | 1976 | Active |
Sri Rajagopalan | Chief Technology Officer | USD 251,296 | Male | 1969 | Active |
Glenn Hillyer | Senior Vice President of Sales Partner Relations | — | Male | 1965 | Active |
Michael Clarkson | Chief Information Security Officer | — | Male | 1975 | Active |
John McStravock | General Counsel | — | Male | — | Active |
Zain Hasan | Chief Growth Officer | — | Male | 1988 | Active |
Lori Babcock | Chief of Staff | — | Female | 1965 | Active |
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Health In Tech NASDAQ: HIT reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million in the year-earlier period, as the company said the onboarding of a new carrier shifted certain policy effective dates into later quarters.

Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.

STUART, Fla., Aug. 3, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the second quarter ended June 30, 2026, following the close of market on Wednesday, August 13, 2026.

STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution.
